Scilex Holding Company (SCLX) has disclosed a new risk, in the Share Price & Shareholder Rights category.
Scilex Holding Company faces considerable market risk, as the biotechnology and pharmaceutical sectors are known for their stock price volatility. From November 2022 to March 2024, Scilex’s stock price exhibited dramatic fluctuations, which could alarm investors. Factors such as commercialization success, patent litigations, and the financial health of partner Sorrento significantly sway Scilex’s stock value. Market trends, sector dynamics, and external influences further intensify this unpredictability, potentially leading to substantial investment losses.
The average SCLX stock price target is $8.00, implying 506.06% upside potential.
To learn more about Scilex Holding Company’s risk factors, click here.
